Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

Griesinger, G; Blockeel, C; Sukhikh, GT; Patki, A; Dhorepatil, B; Yang, DZ; Chen, ZJ; Kahler, E; Pexman-Fieth, C; Tournaye, H

Kahler, E (reprint author), Abbott Labs GmbH, Freundallee 9A, D-30173 Hannover, Germany.

HUMAN REPRODUCTION, 2018; 33 (12): 2212

Abstract

STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索